The most commonly identified PPO using the ACOVE criteria were calcium and vitamin D supplements in patients with osteoporosis (13.3%) and ACE inhibitors or angiotensin-receptor blockers in patients with hypertension and comorbid vascular diseases (10.8%). This evidence concerns the gene ACE and osteoporosis.